Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently... see more

OTCPK:ARLZQ - Post Discussion

Old API Wind-down Ltd - Ordinary Shares > Still Awaiting Consolidated Results
View:
Post by Kisu on Mar 15, 2016 11:23am

Still Awaiting Consolidated Results

Hopefully, Tributes results will have a positive impact.  Couldn't have picked a worse day to release if they tried.  Can't tell how much the downdraft is due to Aralez results, Valient results, or the general market malaise - a perfect storm.
Comment by GoldenDilemma on Mar 15, 2016 11:36am
Nobody cares about Tribute. They want yosprala approval. Since post Hilary, the market has continued to price POZN/TRX (now Aralez) with the tone of "show me what you're made of" and, with projections of Q4 approval there isn't gonna be a whole lot to cause an upswing when all eggs are in the Yosprala basket. too much hope and optomism on this board. I'm underwater at 1.38  ...more  
Comment by GoldenDilemma on Mar 15, 2016 11:40am
And, for the record, management and the fundamentals warrant buying more each time we drop (if you can afford it). 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities